[visionlist] Call for papers - Optometry & Vision Science - Glaucoma Feature Issue 2018

Twa, Michael D mtwa at uab.edu
Wed May 3 13:36:07 -05 2017

Please feel free to distribute to interested colleagues.

Michael Twa, OD PhD
Professor, Associate Dean for Research & Graduate Studies (www.uab.edu/optometry/home/vsgp<http://www.uab.edu/optometry/home/vsgp>)
University of Alabama at Birmingham, School of Optometry (www.uab.edu/optometry/home/<http://www.uab.edu/optometry/home/>)
Editor-in-Chief, Optometry and Vision Science (www.optvissci.com/<http://journals.lww.com/optvissci/pages/advancedsearch.aspx>)

HPB 515 | 1716 University Boulevard | Birmingham, AL 35294-0010
P: 205.934.6724 | mtwa at uab.edu



Intraocular Pressure in Glaucoma

Submission window:     May 1, 2017 to July 31, 2017
Publication date:            January 2018

Glaucoma is a leading cause of irreversible blindness worldwide with an estimated prevalence of 3 million in the United States and more than 120,000 who are blind from this disease. The burden of care associated with glaucoma—to patients and to our health care system—is enormous and growing. In 2010, the Centers for Disease Control estimated that there were more than 10 million visits per year to health care providers attributable to glaucoma. In 1998, the National Eye Institute Glaucoma Panel Report estimated that annual expenditures related to this disease were more than $1.5 billion and surely this has grown since then.

Because glaucoma is such an important public health issue and because January has been designated as Glaucoma Awareness Month, Optometry and Vision Science (OVS) will devote our January issue to this topic over the next several years.

This coming feature issue will focus on research related to intraocular pressure in glaucoma, a very broad and active field of investigation. The link between elevated intraocular pressure and glaucoma is so well-established that it has been characterized as a causative disease factor. Moreover, lowering intraocular pressure remains the primary target for glaucoma therapy.

Optometry and Vision Science believes that it is timely to bring ongoing research efforts to publication in a feature theme issue that informs and advances thinking on this topic for researchers and clinicians alike.

Optometry and Vision Science will publish study results from original research and clinical perspectives together in a single publication in January 2018. Submissions for this feature issue will be coordinated by the Editor-in-Chief and a distinguished Guest Editorial Team:

Andrew Mick, OD, FAAO (Associate Editor, and Feature Issue Lead Editor) – San Francisco Veterans Administration Hospital.
Douglas Anderson, MD (Guest Editor) – Professor Emeritus, Bascom Palmer Eye Institute
J. Crawford Downs, PhD (Guest Editor) – Professor, Vice-chair of Research; Director, Ocular Biomechanics and Biotransport Program, University of Alabama at Birmingham.
Laura Dreer, PhD (Guest Editor) – Associate Professor, Director, Psychological & Neuropsychology Clinical Research Services, University of Alabama at Birmingham.
Murray Fingeret, OD, FAAO (Guest Editor) – Chief of Optometry Section, Brooklyn/St. Albans Campus, Department of Veterans Administration New York Harbor Health Care System.
Thomas Freddo, OD, PhD, FAAO (Editorial Board Member) – Adjunct Professor at MCP Health Sciences University, Worcester, MA.
Chris Johnson, PhD, FAAO (Guest Editor) – Professor, University of Iowa.
John H.K. Liu, Ph.D. (Guest Editor) – Adjunct Professor of Ophthalmology, Director, Glaucoma Molecular Pharmacology Laboratory, University of California, San Diego.

We anticipate that there will be great interest in this publication from clinicians as well as basic and clinical scientists.

Topics targeted for this issue include:

  *   Advances in anterior segment imaging emphasizing the anatomy, physiology, and pathology of glaucoma
  *   Novel drug mechanisms and advances in sustained-release medications for IOP control
  *   Advances in IOP measurement, including continuous monitoring, diurnal rhythms, etc.
  *   The influence of intracranial pressure, ocular perfusion pressure and IOP on glaucoma
  *   Ocular tissue biomechanics and IOP
  *   Care delivery models and the use of technology in screening/telemedicine
  *   The role of patient adherence and health behaviors in glaucoma therapy
Articles will be selected for the Feature Issue by the Guest Editorial team and the Editor-in-Chief based on quality and topical relevance. All papers accepted in the peer review process will be published in OVS in a timely fashion. The window of opportunity for manuscript submission is May 1, 2017, to July 31, 2017. Early submissions are encouraged; and will receive priority for E-publication on the journal website (www.optvissci.com<http://www.optvissci.com>). Publication date: January 2018.

All manuscripts will be peer reviewed and must be submitted online at http://ovs.edmgr.com.<http://ovs.edmgr.com/>

Submissions must be prepared according to the Instructions for Authors available at http://edmgr.ovid.com/ovs/accounts/ifauth.htm. During submission, in the “Author’s Comments” box, note that your paper is being submitted for consideration of this Feature Issue.

Contact the Editorial Office (ovs at osu.edu<mailto:ovs at osu.edu>) for any questions.

Michael D. Twa
Optometry and Vision Science
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://visionscience.com/pipermail/visionlist_visionscience.com/attachments/20170503/2857ef54/attachment-0001.html>

More information about the visionlist mailing list